This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 119/15/2026    most recent CIRCULATIONAHA.108.809491v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maruthur, N. M. Articles by Appel, L. J. Search for Related Content PubMed PubMed Citation Articles by Maruthur, N. M. Articles by Appel, L. J. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Related Collections Behavioral/psychosocial - treatment Primary prevention Chronic ischemic heart disease Related Article

(Circulation. 2009;119:2026-2031.)
© 2009 American Heart Association, Inc.

Coronary Heart Disease

Lifestyle Interventions Reduce Coronary Heart Disease Risk

Results From the PREMIER Trial

Nisa M. Maruthur, MD, MHS; Nae-Yuh Wang, PhD; Lawrence J. Appel, MD, MPH

From the Division of General Internal Medicine (N.M.M., L.J.A.) and the Welch Center for Prevention, Epidemiology, and Clinical Research (N.M.M., N.-Y.W., L.J.A.), The Johns Hopkins University School of Medicine, Baltimore, Md; and Department of Epidemiology (L.J.A.), The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Md.

Reprint requests to Lawrence J. Appel, MD, MPH, 2024 E Monument St, Suite 2-618, Baltimore, MD 21287. E-mail lappel1{at}jhmi.edu

Received July 23, 2008; accepted February 2, 2009.

Background— Although trials of lifestyle interventions generally focus on cardiovascular disease risk factors rather than hard clinical outcomes, 10-year coronary heart disease (CHD) risk can be estimated from the Framingham risk equations. Our objectives were to study the effect of 2 multicomponent lifestyle interventions on estimated CHD risk relative to advice alone and to evaluate whether differences can be observed in the effects of the lifestyle interventions among subgroups defined by baseline variables.

Methods and Results— A total of 810 healthy adults with untreated prehypertension or stage I hypertension were randomized to 1 of 3 intervention groups: An "advice-only" group, an "established" group that used established lifestyle recommendations for blood pressure control (sodium reduction, weight loss, and increased physical activity), or an "established-plus-DASH" group that combined established lifestyle recommendations with the DASH (Dietary Approaches to Stop Hypertension) diet. The primary outcome was 10-year CHD risk, estimated from follow-up data collected at 6 months. A secondary outcome was 10-year CHD risk at 18 months. Of the 810 participants, 62% were women and 34% were black. Mean age was 50 years, mean systolic/diastolic blood pressure was 135/85 mm Hg, and median baseline Framingham risk was 1.9%. The relative risk ratio comparing 6-month to baseline Framingham risk was 0.86 (95% confidence interval 0.81 to 0.91, P<0.001) in the established group and 0.88 (95% confidence interval 0.83 to 0.94, P<0.001) in the established-plus-DASH group relative to advice alone. Results were virtually identical in sensitivity analyses, in each major subgroup, and at 18 months.

Conclusions— The observed reductions of 12% to 14% in estimated CHD risk are substantial and, if achieved, should have important public health benefits.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 119: 2017-2019. [Extract] [Full Text]

This article has been cited by other articles:

				R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, S. Mora, et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1364 - 1405. [Full Text] [PDF]

				WRITING COMMITTEE MEMBERS, R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, et al. ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research Circulation, September 29, 2009; 120(13): 1296 - 1336. [Full Text] [PDF]